Cart
sales@molnova.com
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
CAS No. 146504-07-6
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )
Catalog No. M18038 CAS No. 146504-07-6
Cyclohexanediamine has a potential of anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 63 | In Stock |
|
| 50MG | 90 | In Stock |
|
| 100MG | 120 | In Stock |
|
| 200MG | 168 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclohexanediamine has a potential of anticancer activity.
-
DescriptionCyclohexanediamine has a potential of anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number146504-07-6
-
Formula Weight214.31
-
Molecular FormulaC11H22N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
JBJ-04-125-02
JBJ-04-125-02 (0-1000 nM; 72 hours; H1975 cells) treatment could inhibit cell proliferation of H1975 cells at low nanomolar concentrations.
-
Mutated EGFR-IN-1
Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.
-
Erlotinib hydrochlor...
Erlotinib (CP-358774;OSI-774;NSC 718781) is a potent, selective inhibitor of EGFR with IC50 of 2 nM.
